Otonomy Inc.

Otonomy Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.66
Market Cap
$78.55 M
Shares Outstanding
30.69 M
Public Float
25.01 M

Profile

Address
4796 Executive Drive
San Diego California 92121
United States
Employees -
Website http://www.otonomy.com
Updated 07/08/2019
Otonomy, Inc. is a biopharmaceutical company, which engages in the research, development, and manufacture of therapeutics for otology. The firm's portfolio includes therapeutics for diseases and disorders of the ear such as Ménière's disease, tinnitus, synaptopathy hearing loss, cisplatin-induced loss, severe hearing loss, TTP surgery, and acute otitis externa. It operates under the Otiprio brand.

Financials

View All

Jay B. Lichter
Chairman
David A. Weber
President, Chief Executive Officer & Director